Bristol-Myers Squibb says stops some initiatives in China
LONDON (Reuters) - U.S. drugmaker Bristol-Myers Squibb said on Tuesday it had stopped "certain initiatives" in China, when asked by Reuters to comment on industry chatter it was curbing financial incentives for prescribing doctors.
Aucun commentaire:
Enregistrer un commentaire